Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 3, 2014, Pages 108-110

  Jamuna Rani, A ^a   Mythili, S V ^a  

^a SREE BALAJI MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Antioxidants; Hyperglycaemia; Malondialdehye; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; MALONALDEHYDE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLYCEMIC INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS;

EID: 84896480172     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/7603.4121     Document Type: Article

References (24)

1. Linda C. Tapsell, Lynda J. Gillen, Craig S. Patch, Marijka Batterham, Alice Owen, Marian Baŕe, et al. Including Walnuts in a Low-Fat/Modified-Fat Diet Improves HDL Cholesterol-to- Total Cholesterol Ratios in Patients With Type 2 Diabetes- Diabetes Care. 2004; 27(12): 2777-83.
2. Arzu Akpinar and Bayizit. Analysis of Mineral Content in Pomegranate Juice by ICP-OES. Asian Journal of Chemistry. 2010; 22(8):6542-6.
3. Carl A. Burtis & Edward R. Ashwood. Tietz Text book of Clinical Biochemistry III Edition.Pg.776.
4. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective in an old paradigm. Diabetes. 1999; 48:1-9.
5. John W Baynes. Marek H Dominiczak. Medical Biochemistry second edition. pg 506.
6. Benoît D'Autréaux and Michel B. Toledano.ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature reviews molecular cell biology. 2007; 8: 813.
7. Jeanette Schultz Johansen, Alex K Harris, David J Rychly and Adviye Ergul. Oxidative stress and the use of antioxidants in diabetes linking basic science to clinical practice. Cardiovascular Diabetology. 2005; 4:5.
8. Saxena AK, Srivatsava P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver Effect of vanadate. Biochem Pharmacol. 1993; 45(3):539-42.
9. Feher J, Cosmos G, Vereckei A. Free Radical Reactions in Medicine. Berlin: Springer-Verlag. 1987; link.springer.com/chapter/10.1007/978-3-642-76874-3_1.
10. Erika Szaleczky, József Prechl, János Fehér, Anikó Somogyi. Alterations in enzymatic antioxidant defence in diabetes mellitus - a rational approach. Postgrad Med J. 1999; 75:13-7.
11. Michael Aviram, Mira Rosenblat, Charles L. Bisgaier et al. Paraoxonase inhibits High density Lipoprotein Oxidation and Preserves its function-A Possible Peroxidative Role for Paraoxonase. J.Clin. Invest. 1998; 101(8):1581-90.
12. Shankar Manohar Pawar, Somasekar I Tolanur, T.Mohana Lakshmi, A. Vaithilingam, Chitra Netare and E. Prabhaker Reddy. MDA, FRAP status in Diabetic with Coronary Heart Disease patients. JPBMS. 2011; 4(12):1-4.
13. Chavan VU, Melinkeri RR. Study of protein carbonyl group, nitric oxide and MDA (index of lipid peroxidation) as biomarkers of oxidative stress in type 2 diabetes mellitus. Natl J Community Med. 2013; 4(2):294-9.
14. Rama Srivatsan, Sujata Das, Ranjita Gadde, Krishna, Manoj-Kumar, Snigdha Taduri, Nageswara Rao, et al. Antioxidants and Lipid peroxidation status in Diabetic patients with and without complication. Arch of Iranian Med. 2009; 12(2):121-7.
15. Manjulata Kumawat, Manju Bala Pahwa, Veena Singh Gahlaul and Neelima Singh. Status of Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus with Micro Vascular Complications. The Open Endocrinology Journal. 2009; 3: 12-5.
16. Robby Kumara, Sakil Ahmedb. Antioxidant and lipid peroxidation level in type2 diabetes mellitus. Int J Cur Bio Med Sci. 2011; 1(4): 147-8.
17. Duman BS, Oeztuerk M, Yilmazer S, Hatemi H-Thiols. Malondialdehyde and Total antioxidant status in the Turkish Patients with Type 2 Diabetes Mellitus.Tohoku J Exp Med. 2003; 201(3);147-55.
18. Suchitra MM, Pallavi M, Shivaprasd P, Sachan A, Madusudhana Rao A, Aparna R, et al. Lp(a), Uric Acid, Oxidants and Antioxidant Vitamins in Type 2 Diabetic Patients without Cardiovascular Complications. Journal of Clinical and Diagnostic Research. 2011; 5(6): 1161-4.
19. Isha Hamood and Kassim Salih Abdullah Al Neaimy. Antioxidants in type 2 Diabetic neuropathy. Bahrain Medical Bulletin. 2008; 30(1):1-7.
20. Kalaivanam KN, Dharmalingam M, Marcus SR. Lipid peroxidation in Type 2 diabetes mellitus. Int J.Diab Dev Cltries. 2006; 26:30-2.
21. Ahmed FN, Naqvi FN, Shafiq F. Lipid peroxidation and serum antioxidant enzymes in patients with type 2 Diabetes Mellitus. Ann NY Acad Sci. 2006; 1084: 481-9.
22. Sampath KR, Balasubramanyam M, Tara C, Rema M, Mohan V. Association of hyperglutahionemia with reduced Na+/K+ ATP ase activity in type 2 Diabetes and macroangiopathy. Mol Cell Biochem. 2006; 282:169-76.
23. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in IDMM patients. Diagn Pathol. 2007; 2:22.
24. M. Salem, S. Kholoussi, N. Kholoussi, R. Fawzy. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Archives of Hellenic Medicine. 2011, 28(1):83-8.